M. Saetta (Padova, Italy), N. Roche (Paris, France)
Radiological COPD phenotypes influence BODE
M. Han, J. Curtis, B. Bartholmai, M. Frederick, R. Karwoski, D. Li, A. Limper, F. Sciurba, M. Schwarz, B. Thompson, F. Martinez (Ann Arbor, MI, Rochester, MN, Baltimore, MD, Pittsburgh, PA, Denver, CO, United States Of America)
|  |
The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes
F. Pozo-Rodriguez, C. Esteban Gonzalez, R. Agüero Balbin, A. Capelastegui Sanz, R. Garcia Garcia, C. J. Alvarez (Madrid, Galdakao/Vasque Country, Santander/Cantabria, Spain)
|  |
Is Hoover‘s sign helpful to detect expiratory flow limitation in chronic obstructive pulmonary disease (COPD)?
V. Jacob, M. Bruyneel, C. Sanida, L. Ameye, R. Sergysels, V. Ninane (Brussels, Belgium)
| |
Death causes in COPD inpatients
A. Ferreira, J. de Miguel-Diez, S. Lucero, F. Villar-Alvarez, F. Marta, M. J. Chillon-Martin, L. Puente-Maestu (Madrid, Spain)
| |
Health status and gender predict time to next exacerbation in patients with COPD
J. W. H. Kocks, S. M. Uil, H. Kerstjens, T. Van der Molen, J. W. K. Van den Berg (Groningen, Zwolle, Netherlands)
| |
The correlation of annual rate of FEV1 decline with the temperature of expired air in COPD patients
A. V. Prozorova, A. G. Prikhodko, J. M. Perelman (Blagoveschensk, Russian Federation)
| |
Influence of tobacco-smoking on systemic inflammation (SI) in male and female with COPD
L. Konopkina (Dnipropetrovsk, Ukraine)
| |
The new prognostic multidimensional index HODEH in patient with COPD
N. Karoli, A. Rebrov (Saratov, Russian Federation)
| |
Validation of bode index as a predictor of mortality in COPD patients
P. Sobradillo, M. Iriberri, B. Gomez, J. I. Pijoan, A. Gomez, N. Marina, S. Pedrero (Bilbao, Spain)
| |
Can we predict who is mostly likely to re-exacerbate after a COPD exacerbation?
P. Albert, V. Osman-Hicks, A. Hicks, P. Calverley (Liverpool, United Kingdom)
| |
Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
X. Bu, M. Thompson, A. Hutchinson, D. Smallwood, L. Irving (Beijing, China; Melbourne, Australia)
| |
The survival of patients afflicted with COPD and influencing factors
E. Shehu, J. Bushati, E. Petrela (Tirana, Albania)
| |
Evaluation of physical sings and symptoms in patients with acute exacerbation of COPD
G. Nuralieva, S. Avdeev, A. Chuchalin (Moscow, Russian Federation)
| |
The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients
M. R. De Carlo, M. Moretti, L. M. Fabbri (Modena, Italy)
| |
Predictive factors of endothelial function in patients with chronic obstructive pulmonary disease (COPD)
C. Minet, J. C. Borel, B. Wuyam, P. Faure, J. F. Timsit, C. Pison, P. Levy, J. L. Pepin (Grenoble, France)
| |
Exacerbations of COPD: effect of airflow obstruction and gas transfer on exacerbations reporting and frequency
K. Vijayasaratha, R. Stockley (Birmingham, United Kingdom)
| |
Comparison of dyspnea scoring methods and BODE index with functional parameters in stable COPD
M. Tepetam, A. Fidan, G. Sarac, B. Salepci, N. Kiral, B. Caglayan (Istanbul, Turkey)
| |